| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |